1. Home
  2. ESPR vs EH Comparison

ESPR vs EH Comparison

Compare ESPR & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.65

Market Cap

793.7M

Sector

Health Care

ML Signal

HOLD

Logo EHang Holdings Limited ADS

EH

EHang Holdings Limited ADS

HOLD

Current Price

$10.27

Market Cap

866.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
EH
Founded
2008
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
793.7M
866.0M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
ESPR
EH
Price
$2.65
$10.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$7.60
$21.85
AVG Volume (30 Days)
4.6M
595.3K
Earning Date
03-10-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
60.71
N/A
EPS
N/A
N/A
Revenue
$403,135,000.00
N/A
Revenue This Year
$0.69
$53.34
Revenue Next Year
$10.67
$75.10
P/E Ratio
N/A
N/A
Revenue Growth
21.31
N/A
52 Week Low
$0.73
$9.96
52 Week High
$4.18
$23.34

Technical Indicators

Market Signals
Indicator
ESPR
EH
Relative Strength Index (RSI) 40.23 33.13
Support Level $2.37 N/A
Resistance Level $3.02 $12.80
Average True Range (ATR) 0.20 0.58
MACD -0.00 -0.14
Stochastic Oscillator 38.52 13.87

Price Performance

Historical Comparison
ESPR
EH

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

Share on Social Networks: